Works matching IS 21644403 AND DT 2020 AND VI 10 AND IP 1
Results: 14
Lynparza Now Approved as Maintenance Therapy for BRCA-Mutated Metastatic Pancreatic Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 1, p. 30
- Publication type:
- Article
Xtandi Now Indicated for the Treatment of Metastatic Castration-Sensitive Prostate Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 1, p. 29
- Publication type:
- Article
Tecentriq plus Chemotherapy Approved for First-Line Treatment of Metastatic NSCLC without EGFR or ALK Mutations.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 1, p. 29
- Publication type:
- Article
Value-Based Care Management Medicare Program Changes for 2020 and Beyond.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 1, p. 25
- By:
- Publication type:
- Article
Ensuring Patient Access to Cancer Care Must Be a Priority.
- Published in:
- 2020
- Publication type:
- Proceeding
Real-World Applications of Value-Based Care in Oncology.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 1, p. 22
- Publication type:
- Article
The Future of Cancer Care: Change Is the Only Certainty.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 1, p. 20
- Publication type:
- Article
Psychosocial Issues in Patients with Cancer: It's Time for Real-World Interventions.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 1, p. 18
- By:
- Publication type:
- Article
Steroids plus Exercise Reduce Fatigue in Patients with Advanced Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 1, p. 17
- By:
- Publication type:
- Article
Nivolumab plus Ipilimumab Combination Improves Survival in Patients with Metastatic NSCLC.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 1, p. 14
- By:
- Publication type:
- Article
Genetic Profiling and Personalized Medicine in Myelodysplastic Syndromes.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 1, p. 10
- By:
- Publication type:
- Article
Improving Access to Genetic Cancer Screening in a Medically Underserved Community.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 1, p. 1
- By:
- Publication type:
- Article
Osimertinib Superior TKI as First-Line Treatment of Advanced NSCLC with EGFR Mutation.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 1, p. 1
- By:
- Publication type:
- Article
Biosimilars Are Key Components of Oncology Today: Brush Up on the Basics.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 1, p. 1
- By:
- Publication type:
- Article